Мақаланы E-mail арқылы жіберу Studying of the Mechanisms of Combined Effect of Dexamethasone, Doxorubicin, and Docetaxel on Breast Cancer Cells
- Авторлар: Dukhanina E.A.1, Portseva T.N.1,2, Dukhanin A.S.2, Georgieva S.G.1
-
Мекемелер:
- V. A. Engelhard Institute of Molecular Biology, Russian Academy of Sciences
- N. I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation
- Шығарылым: Том 166, № 1 (2018)
- Беттер: 54-57
- Бөлім: Article
- URL: https://journals.rcsi.science/0007-4888/article/view/240828
- DOI: https://doi.org/10.1007/s10517-018-4288-2
- ID: 240828
Дәйексөз келтіру
Ашық рұқсат
Рұқсат берілді
Тек жазылушылар үшін
Аннотация
The sensitivity of MDA-MB231 breast cancer cells to the effects of pharmacological agents was evaluated by their motility and viability. Dexamethasone, doxorubicin, or docetaxel administered separately in their effective concentration suppressed cell motility (in 16 h) and caused cell death (in 48 h). The strength of the effects increased in the following order: dexa methasone
Авторлар туралы
E. Dukhanina
V. A. Engelhard Institute of Molecular Biology, Russian Academy of Sciences
Хат алмасуға жауапты Автор.
Email: das03@rambler.ru
Ресей, Moscow
T. Portseva
V. A. Engelhard Institute of Molecular Biology, Russian Academy of Sciences; N. I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation
Email: das03@rambler.ru
Ресей, Moscow; Moscow
A. Dukhanin
N. I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation
Email: das03@rambler.ru
Ресей, Moscow
S. Georgieva
V. A. Engelhard Institute of Molecular Biology, Russian Academy of Sciences
Email: das03@rambler.ru
Ресей, Moscow
Қосымша файлдар
